Michael Joseph McGarvey

Michael Joseph McGarvey

Auto-generated profile, based on publicly available information

Michael Joseph McGarvey

Department of Medicine and Histopathology, St. Mary's Hospital, London W2, United Kingdom

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1989 in The Lancet
Verified
Journal Article
Closed access
WCW.F Carman
W.F Carman
SHS Hadziyannis
S Hadziyannis
MMM.J Mcgarvey
M.J Mcgarvey
MJM.R Jacyna
M.R Jacyna
PKPeter Karayiannis
Peter Karayiannis
HTH.C Thomas
H.C Thomas

15 May 2010 in Journal of Virology
Verified
Journal Article
Closed access
SBSamantha Blackham
Samantha Blackham
ABAndrew Baillie
Andrew Baillie
FAFadel Al-Hababi
Fadel Al-Hababi
KRKatja Remlinger
Katja Remlinger
SYShihyun You
Shihyun You
MMMichael J. McGarvey
Michael J. McGarvey
Hepatitis C virus (HCV) is a leading cause of chronic liver disease. The identification and characterization of key host cellular factors that play a role in the HCV replication cycle are important for the understanding of disease pathogenesis and the identification of novel antiviral therapeutic targets. Gene expression profiling of JFH-1-infected Huh7 cells by microarray analysis was performed to identify host cellular genes that are transcriptionally regulated by infection. The expression of host genes involved in cellular defense mechanisms (apoptosis, proliferation, and antioxidant responses), cellular metabolism (lipid and protein metabolism), and intracellular transport (vesicle trafficking and cytoskeleton regulation) was significantly altered by HCV infection. The gene expression patterns identified provide insight into the potential mechanisms that contribute to HCV-associated pathogenesis. These include an increase in proinflammatory and proapoptotic signaling and a decrease in the antioxidant response pathways of the infected cell. To investigate whether any of the host genes regulated by infection were required by HCV during replication, small interfering RNA (siRNA) silencing of host gene expression in HCV-infected cells was performed. Decreasing the expression of host genes involved in lipid metabolism (TXNIP and CYP1A1 genes) and intracellular transport (RAB33b and ABLIM3 genes) reduced the replication and secretion of HCV, indicating that they may be important factors for the virus replication cycle. These results show that major changes in the expression of many different genes in target cells may be crucial in determining the outcome of HCV infection.

1 April 2001 in Journal of General Virology
Verified
Journal Article
Closed access
FHFrank Henkler
Frank Henkler
JHJonathan Hoare
Jonathan Hoare
NWNaushin Waseem
Naushin Waseem
RGRobert D. Goldin
Robert D. Goldin
MMMichael J. McGarvey
Michael J. McGarvey
IKIan A. King
Ian A. King
The hepatitis B virus (HBV) X protein (HBx) was originally suggested to be a viral transcriptional activator, but its functional mechanisms are still unclear. In this study we have analysed the intracellular localization of HBx in transfected cells and demonstrate that its compartmentalization is dependent on overall expression levels. HBx was exclusively or predominantly localized in the nuclei in weakly expressing cells. However, elevated cellular levels correlated with its accumulation in the cytoplasm, suggesting that the capacity of HBx for nuclear compartmentalization might be limited. Cytoplasmic HBx was detected either as punctate granular staining or in dispersed, finely granular patterns. We have further analysed the detailed cytoplasmic compartmentalization, using confocal microscopy, and show no association with the endoplasmic reticulum, plasma membrane or lysosomes, but a substantial association of HBx with mitochondria. However, a major fraction of cytoplasmic HBx did not localize in mitochondria, indicating the presence of two distinctly compartmentalized cytoplasmic populations. Furthermore, high levels of HBx expression led to an abnormal mitochondrial distribution, involving clumping and organelle aggregation, which was not observed at lower expression levels. The data presented here provide novel insights into the compartmentalization of HBx and may prove important for future evaluations of its functions, both in the viral life-cycle and in the pathology of HBV-related liver disease.

1 March 1999 in Journal of General Virology
Verified
Journal Article
Closed access
AWA D Wardell
A D Wardell
WEW Errington
W Errington
GCG Ciaramella
G Ciaramella
JMJ Merson
J Merson
MMM J McGarvey
M J McGarvey
The non-structural protein 3 (NS3) of hepatitis C virus (HCV) possesses three activities which are likely to be essential for virus replication; a serine protease located in the N terminus and helicase and NTPase activities located in the C terminus. Sequence analysis of the helicase/NTPase domain has identified motifs indicative of the DEAD-box family of helicases. Here we present the characterization of the helicase and NTPase activities of full-length NS3, expressed as a His-tagged fusion protein in E. coli, and make comparisons with published data of NS3 helicase domain alone. The helicase and NTPase activities of full-length NS3 have been demonstrated and we have characterized the effects of amino acid substitutions on conserved motifs of NS3 helicase. Helicase and NTPase activities were dependent on Mg2+ and ATP and inhibited by monovalent cations. NS3 was able to hydrolyse all four NTPs and dNTPs to drive DNA duplex unwinding but with differing abilities. NTPase activity was stimulated by all polynucleotides tested, with poly(U) having the greatest effect. Mutational analysis of conserved motifs of NS3 helicase showed all conserved residues to be required for optimal activity. These results are in accord with a recently proposed model for NS3 helicase activity.

1 August 1998 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
DODiarmuid R. O’donnell
Diarmuid R. O’donnell
MMMichael J. McGarvey
Michael J. McGarvey
JTJoanna M. Tully
Joanna M. Tully
IBIan M. Balfour-Lynn
Ian M. Balfour-Lynn
POPeter J.M. Openshaw
Peter J.M. Openshaw

13 July 2001 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
JHJonathan Hoare
Jonathan Hoare
FHFrank Henkler
Frank Henkler
JDJason J. Dowling
Jason J. Dowling
WEWilliam Errington
William Errington
RGRobert D. Goldin
Robert D. Goldin
MMMichael J. McGarvey
Michael J. McGarvey